REVIEWER: Ulfar Helgason, CIO and corporate controller for Actavis Pharmaceutical.

BACKGROUND: Iceland's Actavis Pharmaceutical is one of the world's top-five makers of generics. Founded in 1956, Actavis now operates across five continents with operations principally focused in Turkey, Germany, Bulgaria, Serbia, Russia and recently the U.S. Through a series of acquisitions, the company has expanded from just 100 people five years ago to more than 10,000 experienced pharmacists, chemists and other professionals in 32 countries. Its manufacturing plants worldwide produce a variety of medicines in different formulations.

Register or login for access to this item and much more

All Information Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access